CanaQuest Medical Corp Overview Q3 2024 - Brochure

CanaQuest Medical Corp. (CANQF) is a clinical-stage life sciences company that specializes in developing innovative cannabinoid-based therapeutics. The company`s primary focus is on CQ-001, a proprietary drug candidate that combines cannabidiol (CBD) with essential fatty acids (Omega-3s). Prior research and animal studies have demonstrated CQ-001`s synergistic effects and enhanced ability to bind to critical “PPAR” receptors in the brain, which play a key role in cellular regulation and metabolism. This formulation has shown increased potency and effectiveness in addressing epilepsy.